SpringWorks Therapeutics, Inc.

NasdaqGS:SWTX 주식 보고서

시가총액: US$2.9b

SpringWorks Therapeutics 관리

관리 기준 확인 2/4

SpringWorks Therapeutics CEO는 Saqib Islam, Jul2018 에 임명되었습니다 의 임기는 6.33 년입니다. 총 연간 보상은 $ 18.35M, 4% 로 구성됩니다. 4% 급여 및 96% 보너스(회사 주식 및 옵션 포함). 는 $ 27.05M 가치에 해당하는 회사 주식의 0.93% 직접 소유합니다. 27.05M. 경영진과 이사회의 평균 재임 기간은 각각 4.5 년과 5.3 년입니다.

주요 정보

Saqib Islam

최고 경영자

US$18.4m

총 보상

CEO 급여 비율4.0%
CEO 임기6.3yrs
CEO 소유권0.9%
경영진 평균 재임 기간4.5yrs
이사회 평균 재임 기간5.3yrs

최근 관리 업데이트

Recent updates

Here's What Analysts Are Forecasting For SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) After Its Third-Quarter Results

Nov 15
Here's What Analysts Are Forecasting For SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) After Its Third-Quarter Results

SpringWorks Therapeutics Merits A Speculative Buy

Nov 04

SpringWorks Therapeutics: Rising On A Strong Post-Launch Quarter, Now Justified As A Buy

Aug 07

Need To Know: Analysts Are Much More Bullish On SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Revenues

May 11
Need To Know: Analysts Are Much More Bullish On SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Revenues

We Think SpringWorks Therapeutics (NASDAQ:SWTX) Can Afford To Drive Business Growth

May 03
We Think SpringWorks Therapeutics (NASDAQ:SWTX) Can Afford To Drive Business Growth

SpringWorks Therapeutics: Newly Commercial Stage, Fully Valued Biotech Means Steer Clear

Apr 25

SpringWorks Therapeutics: Multiple Opportunities, But No Sure-Fire Winners

Apr 19

We Think SpringWorks Therapeutics (NASDAQ:SWTX) Can Afford To Drive Business Growth

Sep 20
We Think SpringWorks Therapeutics (NASDAQ:SWTX) Can Afford To Drive Business Growth

We're Not Very Worried About SpringWorks Therapeutics' (NASDAQ:SWTX) Cash Burn Rate

Jun 07
We're Not Very Worried About SpringWorks Therapeutics' (NASDAQ:SWTX) Cash Burn Rate

We Think SpringWorks Therapeutics (NASDAQ:SWTX) Can Afford To Drive Business Growth

Feb 22
We Think SpringWorks Therapeutics (NASDAQ:SWTX) Can Afford To Drive Business Growth

Here's Why We're Not Too Worried About SpringWorks Therapeutics' (NASDAQ:SWTX) Cash Burn Situation

Nov 09
Here's Why We're Not Too Worried About SpringWorks Therapeutics' (NASDAQ:SWTX) Cash Burn Situation

SpringWorks drops 21% as Allogene drops lead asset in combination study

Aug 10

SpringWorks Therapeutics GAAP EPS of -$1.41 misses by $0.15

Aug 04

Sizing Up SpringWorks Therapeutics

Jul 20

Will SpringWorks Therapeutics (NASDAQ:SWTX) Spend Its Cash Wisely?

Jun 06
Will SpringWorks Therapeutics (NASDAQ:SWTX) Spend Its Cash Wisely?

SpringWorks Therapeutics: Rating Buy Ahead Of Mid-Year Data Releases

May 02

Companies Like SpringWorks Therapeutics (NASDAQ:SWTX) Can Afford To Invest In Growth

Dec 30
Companies Like SpringWorks Therapeutics (NASDAQ:SWTX) Can Afford To Invest In Growth

SpringWorks Is A Biotech To Watch With Several Partnerships And Solid Drug Pipeline

Dec 14

SpringWorks Therapeutics (NASDAQ:SWTX) Is In A Strong Position To Grow Its Business

Sep 15
SpringWorks Therapeutics (NASDAQ:SWTX) Is In A Strong Position To Grow Its Business

CEO 보상 분석

Saqib Islam 의 보수는 SpringWorks Therapeutics 의 수익과 비교하여 어떻게 변경되었나요?
날짜총 보상급여회사 수익
Sep 30 2024n/an/a

-US$275m

Jun 30 2024n/an/a

-US$301m

Mar 31 2024n/an/a

-US$339m

Dec 31 2023US$18mUS$725k

-US$325m

Sep 30 2023n/an/a

-US$305m

Jun 30 2023n/an/a

-US$298m

Mar 31 2023n/an/a

-US$289m

Dec 31 2022US$15mUS$680k

-US$277m

Sep 30 2022n/an/a

-US$259m

Jun 30 2022n/an/a

-US$228m

Mar 31 2022n/an/a

-US$206m

Dec 31 2021US$18mUS$590k

-US$174m

Sep 30 2021n/an/a

-US$107m

Jun 30 2021n/an/a

-US$87m

Mar 31 2021n/an/a

-US$60m

Dec 31 2020US$8mUS$541k

-US$46m

Sep 30 2020n/an/a

-US$73m

Jun 30 2020n/an/a

-US$68m

Mar 31 2020n/an/a

-US$62m

Dec 31 2019US$3mUS$480k

-US$51m

Sep 30 2019n/an/a

-US$41m

Jun 30 2019n/an/a

-US$29m

Mar 31 2019n/an/a

-US$18m

Dec 31 2018US$2mUS$407k

-US$18m

보상 대 시장: Saqib 의 총 보상 ($USD 18.35M )은 US 시장( $USD 6.56M ).

보상과 수익: 회사가 수익성이 없는 동안 Saqib 의 보상이 증가했습니다.

CEO

Saqib Islam (54 yo)

6.3yrs

테뉴어

US$18,351,489

보상

Mr. Saqib Islam, J.D. has been Chief Executive Officer and Director at SpringWorks Therapeutics, Inc. since August 2018. He serves as an Independent Director of Passage Bio, Inc. since March 2019. Mr. Isla...

리더십 팀

이름위치테뉴어보상소유권
Saqib Islam
CEO & Director6.3yrsUS$18.35m0.93%
$ 27.1m
Francis Perier
Chief Financial Officer5.3yrsUS$3.74m0.025%
$ 729.2k
Badreddin Edris
Chief Operating Officer3.8yrsUS$6.64m0.21%
$ 6.1m
James Cassidy
Chief Medical Officer3.3yrsUS$4.31m0.031%
$ 900.4k
Michael Nofi
Chief Accounting Officer4.7yrs데이터 없음0.0083%
$ 240.3k
Tai-An Lin
Chief Scientific Officer1.2yrs데이터 없음0.0075%
$ 218.5k
Kim Diamond
Vice President of Communications & Investor Relations6.8yrs데이터 없음데이터 없음
Herschel Weinstein
General Counsel & Secretary4.8yrsUS$2.83m0.018%
$ 531.6k
Daniel Pichl
Chief People Officer4.3yrsUS$2.52m0.0065%
$ 188.6k
Bhavesh Ashar
Chief Commercial Officer3.7yrsUS$4.94m0.014%
$ 400.4k

4.5yrs

평균 재임 기간

56yo

평균 연령

경험이 풍부한 관리: SWTX 의 관리팀은 경험 ( 4.5 년 평균 재직 기간)으로 간주됩니다.

이사회 구성원

이름위치테뉴어보상소유권
Saqib Islam
CEO & Director6.3yrsUS$18.35m0.93%
$ 27.1m
Alan Fuhrman
Independent Director5.3yrsUS$520.14k0.014%
$ 412.6k
Daniel Lynch
Independent Chairman of the Board8.8yrsUS$545.14k0.41%
$ 11.8m
Martin MacKay
Directorless than a year데이터 없음데이터 없음
Freda Lewis-Hall
Independent Director7.3yrsUS$508.45k0.014%
$ 412.6k
Carlos Alban
Independent Director2.3yrsUS$507.64k0.011%
$ 312.2k
Julie Hambleton
Independent Director4.5yrsUS$520.14k데이터 없음

5.3yrs

평균 재임 기간

66yo

평균 연령

경험이 풍부한 이사회: SWTX 의 이사회는 경험(평균 재직 기간 5.3 년)으로 간주됩니다.